Author:
Ramaswamy Anant,Joshi Amit,Noronha Vanita,Patil Vijay M.,Kothari Rushabh,Sahu Arvind,Kannan Ram Abhinav,Sable Nilesh,Popat Palak,Menon Santosh,Prabhash Kumar
Reference30 articles.
1. External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study;Heng;Lancet Oncol,2013
2. Cabozantinib versus everolimus in advanced renal-cell carcinoma;Choueiri;N Engl J Med,2015
3. The evolution of nephrectomy and patient characteristics in metastatic renal cell carcinoma patients enrolled into first-line tyrosine kinase inhibitors clinical trials;Sella;Clin Genitourin Cancer,2016
4. Economic burden of oral tyrosine kinase inhibitors among privately insured patients diagnosed with metastatic renal cell carcinoma;Am J Pharm Benefits,2015
5. Concurrent chemoradiation for cancer of the cervix: results of a multi-institutional study from the setting of a developing country (India);Nandakumar;J Glob Oncol,2015
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献